(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

METUCHEN PHARMACEUTICALS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

METUCHEN PHARMACEUTICALS

ST13

US500000088654578

Class

41

Filing

88654578

Registration

6143944

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

09/02/2025

Trademark type

Combined

Nice classes

41

Filing date

10/15/2019

Registration date

09/01/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/01/2020

Last transaction

09/02/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

07/14/2020

First use in commerce

07/14/2020

Drawing code

3

Owner type

16

Owner location

FREEHOLD, NJ

Examiner

HARMON, RAYMOND

Law office

L30

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized navy word "METUCHEN" above the stylized navy word "PHARMACEUTICALS" in smaller text with a navy line dividing them. "PHARMACEUTICALS" starts with a capital letter. There is a navy square box outlined in the upper right hand corner. The color white represents background, shading and transparent areas and is not a feature of the mark.

Holders and representatives

Holders

Metuchen Pharmaceuticals, LLC
Metuchen Pharmaceuticals, LLC

Representatives

Mark Pohl Pharmaceutical Patent Attorneys, LLC

Technical classification

Nice Classes

Class 41

Vienna Codes

No Vienna codes available.

Goods and services

Class 41

Providing a website with information on the proper use of prescription pharmaceuticals; Providing a website with information on co-pay and similar prescription pharmaceutical purchasing programs

Publications

History of USPTO decisions and trademark events.

29 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

09/01/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/31/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/31/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/31/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/31/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

12/31/2020

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

09/01/2020

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

07/27/2020

ALIE

ASSIGNED TO LIE

07/20/2020

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

07/17/2020

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

07/16/2020

IUAA

USE AMENDMENT ACCEPTED

07/16/2020

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

07/15/2020

IUAF

USE AMENDMENT FILED

07/15/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

07/15/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/15/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

07/15/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/15/2020

EAAU

TEAS AMENDMENT OF USE RECEIVED

07/14/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/14/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/14/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/14/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/15/2020

GNRT

NON-FINAL ACTION E-MAILED

01/15/2020

CNRT

NON-FINAL ACTION WRITTEN

01/15/2020

DOCK

ASSIGNED TO EXAMINER

01/14/2020

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

10/19/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/18/2019

NWAP

NEW APPLICATION ENTERED

10/18/2019

Continuous trademark protection

Get notified about every new filing that threatens METUCHEN PHARMACEUTICALS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.